These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 7812969

  • 1. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.
    Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo KT, Yeo TK, Sioussat TM, Dvorak HF.
    Cancer Res; 1995 Jan 15; 55(2):360-8. PubMed ID: 7812969
    [Abstract] [Full Text] [Related]

  • 2. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining.
    Nagy JA, Morgan ES, Herzberg KT, Manseau EJ, Dvorak AM, Dvorak HF.
    Cancer Res; 1995 Jan 15; 55(2):376-85. PubMed ID: 7529135
    [Abstract] [Full Text] [Related]

  • 3. Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity.
    Nagy JA, Meyers MS, Masse EM, Herzberg KT, Dvorak HF.
    Cancer Res; 1995 Jan 15; 55(2):369-75. PubMed ID: 7812970
    [Abstract] [Full Text] [Related]

  • 4. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
    Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF.
    Cancer Res; 1993 Jun 15; 53(12):2912-8. PubMed ID: 8504432
    [Abstract] [Full Text] [Related]

  • 5. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
    Luo JC, Toyoda M, Shibuya M.
    Cancer Res; 1998 Jun 15; 58(12):2594-600. PubMed ID: 9635584
    [Abstract] [Full Text] [Related]

  • 6. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels.
    Feng D, Nagy JA, Dvorak AM, Dvorak HF.
    Microvasc Res; 2000 Jan 15; 59(1):24-37. PubMed ID: 10625568
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K, Noguchi M.
    Oncol Rep; 2003 Jan 15; 10(1):89-95. PubMed ID: 12469150
    [Abstract] [Full Text] [Related]

  • 8. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors.
    Luo JC, Yamaguchi S, Shinkai A, Shitara K, Shibuya M.
    Cancer Res; 1998 Jun 15; 58(12):2652-60. PubMed ID: 9635593
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
    Sioussat TM, Dvorak HF, Brock TA, Senger DR.
    Arch Biochem Biophys; 1993 Feb 15; 301(1):15-20. PubMed ID: 8442657
    [Abstract] [Full Text] [Related]

  • 10. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
    Roberts WG, Hasan T.
    Cancer Res; 1993 Jan 01; 53(1):153-7. PubMed ID: 8416739
    [Abstract] [Full Text] [Related]

  • 11. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
    Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF.
    Cancer Res; 1993 Oct 01; 53(19):4727-35. PubMed ID: 8402650
    [Abstract] [Full Text] [Related]

  • 12. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.
    Senger DR, Perruzzi CA, Feder J, Dvorak HF.
    Cancer Res; 1986 Nov 01; 46(11):5629-32. PubMed ID: 3756910
    [Abstract] [Full Text] [Related]

  • 13. Suppression of ascites formation and re-accumulation associated with human ovarian cancer by an anti-VPF monoclonal antibody in vivo.
    Yukita A, Asano M, Okamoto T, Mizutani S, Suzuki H.
    Anticancer Res; 2000 Nov 01; 20(1A):155-60. PubMed ID: 10769648
    [Abstract] [Full Text] [Related]

  • 14. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF.
    Lab Invest; 1996 Jun 01; 74(6):1105-15. PubMed ID: 8667614
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor is increased in ascites from metastatic pancreatic cancer.
    Liu CD, Tilch L, Kwan D, McFadden DW.
    J Surg Res; 2002 Jan 01; 102(1):31-4. PubMed ID: 11792148
    [Abstract] [Full Text] [Related]

  • 16. Vascular permeability factor gene expression in normal and neoplastic human ovaries.
    Olson TA, Mohanraj D, Carson LF, Ramakrishnan S.
    Cancer Res; 1994 Jan 01; 54(1):276-80. PubMed ID: 8261452
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
    Pötgens AJ, van Altena MC, Lubsen NH, Ruiter DJ, de Waal RM.
    Am J Pathol; 1996 Apr 01; 148(4):1203-17. PubMed ID: 8644861
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.
    Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, Van de Water L.
    J Immunol; 1995 Mar 15; 154(6):2801-7. PubMed ID: 7876550
    [Abstract] [Full Text] [Related]

  • 19. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 20. Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation.
    Nagy JA, Herzberg KT, Dvorak JM, Dvorak HF.
    Cancer Res; 1993 Jun 01; 53(11):2631-43. PubMed ID: 8495427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.